Role of the Pharmacoeconomic Aspects in the Clinical Management of Hypertension.
High Blood Press Cardiovasc Prev
; 23(2): 151-4, 2016 Jun.
Article
em En
| MEDLINE
| ID: mdl-27160719
ABSTRACT
Hypertension constitutes a significant disease burden to the society, both in terms of the health-related repercussions as well as financial costs incurred due to morbidity and the cumulative cost of drug therapy. In the real world, it would be useful to have the opportunity to consider the appropriate use of antihypertensive drugs to inform and guide clinical practice. To evaluate the adherence of drugs prescriptions in clinical practice according to predefined standards of care, a series of indicators measurable in relation to specific conditions have been developed. This work presents four indicators the first related to the use of drugs acting on the renin-angiotensin system in patients at high cardiovascular risk; the second related to the use of angiotensin II antagonists with expired patent; the third related the occasional prescription of antihypertensive drugs; and the fourth on the adherence to treatment with antihypertensive drugs. The four indicators were measured in the OsMed database.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Sistema Renina-Angiotensina
/
Pressão Sanguínea
/
Custos de Medicamentos
/
Adesão à Medicação
/
Hipertensão
/
Anti-Hipertensivos
Tipo de estudo:
Diagnostic_studies
/
Guideline
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
High Blood Press Cardiovasc Prev
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
Itália